RedHill Biopharma Ltd. announced that on June 4, 2024 Ms. Alla Felder submitted to the board of directors a notice of resignation from her position as a member of the Board, effective June 6, 2024. Ms. Felder?s resignation from the Board is due to personal reasons and not as a result of any disagreement with the Company on any matter relating to the Company?s operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3626 USD | +0.17% |
|
-3.87% | -75.16% |
Jun. 06 | RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board | CI |
May. 06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
1st Jan change | Capi. | |
---|---|---|
-75.16% | 11.55M | |
+4.57% | 96.72B | |
+5.66% | 41.43B | |
-13.20% | 32.7B | |
+82.38% | 29.06B | |
-16.02% | 15.38B | |
-8.17% | 12.97B | |
-13.35% | 11.36B | |
+160.91% | 9.9B | |
+3.07% | 8.93B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board